Related Experiment Video
Updated: Aug 26, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Post-acute anti-NMDAR encephalitis mirrors schizophrenia.
Sergio Muñiz-Castrillo1, Alberto Vogrig2, Jérôme Honnorat3
1French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, USA.
The cognitive and psychiatric symptoms following anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis resemble schizophrenia. However, NMDAR encephalitis patients showed symptom improvement, unlike schizophrenia patients.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- The long-term cognitive and psychiatric effects of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis are not well understood.
- Anti-NMDAR encephalitis is an autoimmune disorder affecting the central nervous system.
Purpose of the Study:
- To investigate the post-acute evolution of neuropsychiatric symptoms in anti-NMDAR encephalitis.
- To compare these symptoms with those of schizophrenia.
Main Methods:
- The study analyzed patients with anti-NMDAR encephalitis in the post-acute phase.
- Neuropsychiatric symptoms were assessed and compared to established schizophrenia profiles.
Main Results:
- Neuropsychiatric symptoms in the post-acute phase of anti-NMDAR encephalitis were similar to those seen in schizophrenia.
- Patients with anti-NMDAR encephalitis demonstrated improvement in their symptoms over time, a contrast to schizophrenia.
Conclusions:
- The findings suggest a potential overlap in the clinical presentation of post-acute anti-NMDAR encephalitis and schizophrenia.
- The observed symptom improvement in NMDAR encephalitis patients highlights a key difference and potential therapeutic implications.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Schizophrenia
Psychosis: Goals of Pharmacotherapy